Sjogren’s Syndrome – Epidemiology – Epidemiology Dashboard
The epidemiology dashboard allows users to view epidemiological forecasts for 45 countries all in one place, displayed in the following formats:
- A heat map view of the number of cases in each country or the corresponding incidence or prevalence estimate.
- A customizable bar chart of cases or a bubble plot demonstrating the association of the disease with healthcare spend per capita.
- A patient-flow diagram with options to display data for certain countries or regions and forecast years.
The dashboard allows users to export the diagram or chart as an image file that can easily be incorporated into internal or investor/shareholder material.
The epidemiology dashboard is available as an Excel file in the Download’s section at the top right of this page. It is available only to clients with subscriptions to all 45 countries covered by Clarivate Epidemiology. For subscription and entitlement queries or requests for customized versions of the epidemiology dashboard, such as including additional countries or patient populations, please contact Clarivate.support@clarivate.com.
Please note that you may need to update your version of Microsoft Excel to access all the functionality in this dashboard.
Mohani Latwal, B.P.T., M.P.H., Epidemiologist, Epidemiology. Prior to joining Clarivate, she worked as a deputy manager at an NGO. She received her bachelor’s degree in physiotherapy from Delhi University and her master’s degree in public health with a specialization in social epidemiology from the Tata Institute of Social Sciences in Mumbai.
Surup Dey, M.L.T., M.P.H., is an epidemiologist at Clarivate. A former microbiologist, he was involved in the diagnosis of rare hematological disorders. Mr. Dey has a background in medical laboratory science from Christian Medical College in Vellore and earned a postgraduate degree in public health specializing in epidemiology from Manipal University. He specializes in real-world data analysis, cancer epidemiology, rare disease epidemiology, and targeted therapies in cancer.